AI-powered analysis of cellular senescence for aging research, cancer therapy response, and senolytic drug development.
BY FreedomIntelligenceUPDATED Oct 27, 2026
INTENDED FOR✳Claude Code>_Codex◈OpenClaw↗CursorInstall in a listed agent.
instructions.md
---
name: 'cellular-senescence-agent'
description: 'AI-powered analysis of cellular senescence for aging research, cancer therapy response, and senolytic drug development.'
measurable_outcome: Execute skill workflow successfully with valid output within 15 minutes.
allowed-tools:
- read_file
- run_shell_command
---
<!--
# COPYRIGHT NOTICE
# This file is part of the "Universal Biomedical Skills" project.
# Copyright (c) 2026 MD BABU MIA, PhD <md.babu.mia@mssm.edu>
# All Rights Reserved.
#
# This code is proprietary and confidential.
# Unauthorized copying of this file, via any medium is strictly prohibited.
#
# Provenance: Authenticated by MD BABU MIA
-->
# Cellular Senescence Agent
The **Cellular Senescence Agent** provides comprehensive AI-driven analysis of cellular senescence signatures for aging research, cancer biology, and senolytic therapeutic development.
## When to Use This Skill
* When identifying senescent cells in tissue or single-cell data.
* To analyze senescence-associated secretory phenotype (SASP).
* For predicting senolytic drug sensitivity.
* When studying therapy-induced senescence in cancer.
* To assess senescence burden in aging and disease.
## Core Capabilities
1. **Senescence Scoring**: Calculate senescence signatures from transcriptomic data.
2. **SASP Profiling**: Characterize senescence-associated secretory phenotype composition.
3. **Single-Cell Detection**: Identify senescent cells in scRNA-seq data.
4. **Senolytic Prediction**: Predict sensitivity to senolytic drugs.
5. **Tissue Aging**: Assess senescence burden across tissues.
6. **Cancer Senescence**: Analyze therapy-induced senescence.
## Senescence Markers
| Category | Markers | Detection |
|----------|---------|-----------|
| Cell cycle | p16INK4a, p21CIP1, p53 | Expression, IHC |
| SA-β-gal | GLB1 (lysosomal) | Activity assay |
| SASP | IL-6, IL-8, MMP3, PAI-1 | Expression, secretion |
| DNA damage | γH2AX, 53BP1 foci | Immunofluorescence |
| Morphology | Enlarged, flattened | Imaging |
| Epigenetic | SAHF, SAHMs | Chromatin marks |
## Workflow
1. **Input**: Bulk or single-cell RNA-seq, proteomics, imaging data.
2. **Signature Scoring**: Apply senescence gene signatures.
3. **SASP Analysis**: Profile secretory phenotype.
4. **Cell Identification**: Flag senescent cells (single-cell).
5. **Senolytic Prediction**: Match to drug sensitivity profiles.
6. **Burden Estimation**: Quantify senescence load.
7. **Output**: Senescence scores, SASP profile, drug recommendations.
## Example Usage
**User**: "Analyze senescence signatures in this aging tissue dataset and identify senolytic candidates."
**Agent Action**:
```bash
python3 Skills/Longevity_Aging/Cellular_Senescence_Agent/senescence_analyzer.py \
--rnaseq tissue_expression.tsv \
--singlecell tissue_scrnaseq.h5ad \
--signatures fridman_sasp,reactome_senescence \
--senolytic_prediction true \
--tissue liver \
--output senescence_report/
```
## Senescence Gene Signatures
| Signature | Genes | Application |
|-----------|-------|-------------|
| Fridman (2017) | CDKN1A, CDKN2A, SERPINE1... | Pan-senescence |
| SenMayo | 125 genes | Tissue senescence |
| SASP Core | IL6, IL8, CXCL1, MMP1... | Secretory phenotype |
| p16/p21 pathway | CDKN2A, CDKN1A, MDM2... | Cell cycle arrest |
## SASP Components
**Pro-inflammatory**:
- Interleukins: IL-1α/β, IL-6, IL-8
- Chemokines: CXCL1, CXCL2, CCL2
- Growth factors: TGF-β, VEGF
**Matrix Remodeling**:
- MMPs: MMP1, MMP3, MMP10
- Serpins: PAI-1 (SERPINE1)
**Effects on Microenvironment**:
- Paracrine senescence spread
- Immune cell recruitment
- ECM remodeling
- Tumor promotion (chronic) vs suppression (acute)
## Senolytic Drugs
| Drug | Target | Clinical Status |
|------|--------|-----------------|
| Dasatinib | Src/tyrosine kinases | Trials (with Q) |
| Quercetin | PI3K, serpins | Trials (with D) |
| Navitoclax | BCL-2/BCL-xL | Trials |
| Fisetin | Multiple | Early trials |
| UBX1325 | BCL-xL | Phase 2 (macular) |
## AI/ML Components
**Senescence Classifier**:
- Multi-gene signature scoring
- ML classifiers on expression
- Single-cell senescence probability
**Drug Response**:
- GDSC/CCLE senescence sensitivity
- SASP-drug correlations
- Synergy predictions
**Aging Clock Integration**:
- Epigenetic age correlation
- Transcriptomic age
- Senescence-aging relationships
## Cancer Applications
**Therapy-Induced Senescence (TIS)**:
- Chemotherapy, radiation
- CDK4/6 inhibitors (palbociclib)
- Dual outcomes: tumor suppression vs SASP-driven recurrence
**Senescence + Senolytics**:
- Induce senescence → clear with senolytics
- "One-two punch" approach
- Clinical trials ongoing
## Prerequisites
* Python 3.10+
* Gene signature tools (GSVA, ssGSEA)
* Single-cell analysis (Scanpy)
* Drug response databases
## Related Skills
* Single_Cell - For scRNA-seq analysis
* Cancer_Metabolism_Agent - For metabolic senescence
* Tumor_Microenvironment - For SASP effects
## Research Applications
1. **Aging Research**: Quantify senescence burden
2. **Cancer Therapy**: Monitor TIS response
3. **Drug Development**: Senolytic efficacy
4. **Fibrosis**: Senescence in fibrotic disease
5. **Regeneration**: Senescence in tissue repair
## Author
AI Group - Biomedical AI Platform
<!-- AUTHOR_SIGNATURE: 9a7f3c2e-MD-BABU-MIA-2026-MSSM-SECURE -->
---
name: 'cellular-senescence-agent'
description: 'AI-powered analysis of cellular senescence for aging research, cancer therapy response, and senolytic drug development.'
measurable_outcome: Execute skill workflow successfully with valid output within 15 minutes.
allowed-tools:
- read_file
- run_shell_command
---
<!--
# COPYRIGHT NOTICE
# This file is part of the "Universal Biomedical Skills" project.
# Copyright (c) 2026 MD BABU MIA, PhD <md.babu.mia@mssm.edu>
# All Rights Reserved.
#
# This code is proprietary and confidential.
# Unauthorized copying of this file, via any medium is strictly prohibited.
#
# Provenance: Authenticated by MD BABU MIA
-->
# Cellular Senescence Agent
The **Cellular Senescence Agent** provides comprehensive AI-driven analysis of cellular senescence signatures for aging research, cancer biology, and senolytic therapeutic development.
## When to Use This Skill
* When identifying senescent cells in tissue or single-cell data.
* To analyze senescence-associated secretory phenotype (SASP).
* For predicting senolytic drug sensitivity.
* When studying therapy-induced senescence in cancer.
* To assess senescence burden in aging and disease.
## Core Capabilities
1. **Senescence Scoring**: Calculate senescence signatures from transcriptomic data.
2. **SASP Profiling**: Characterize senescence-associated secretory phenotype composition.
3. **Single-Cell Detection**: Identify senescent cells in scRNA-seq data.
4. **Senolytic Prediction**: Predict sensitivity to senolytic drugs.
5. **Tissue Aging**: Assess senescence burden across tissues.
6. **Cancer Senescence**: Analyze therapy-induced senescence.
## Senescence Markers
| Category | Markers | Detection |
|----------|---------|-----------|
| Cell cycle | p16INK4a, p21CIP1, p53 | Expression, IHC |
| SA-β-gal | GLB1 (lysosomal) | Activity assay |
| SASP | IL-6, IL-8, MMP3, PAI-1 | Expression, secretion |
| DNA damage | γH2AX, 53BP1 foci | Immunofluorescence |
| Morphology | Enlarged, flattened | Imaging |
| Epigenetic | SAHF, SAHMs | Chromatin marks |
## Workflow
1. **Input**: Bulk or single-cell RNA-seq, proteomics, imaging data.
2. **Signature Scoring**: Apply senescence gene signatures.
3. **SASP Analysis**: Profile secretory phenotype.
4. **Cell Identification**: Flag senescent cells (single-cell).
5. **Senolytic Prediction**: Match to drug sensitivity profiles.
6. **Burden Estimation**: Quantify senescence load.
7. **Output**: Senescence scores, SASP profile, drug recommendations.
## Example Usage
**User**: "Analyze senescence signatures in this aging tissue dataset and identify senolytic candidates."
**Agent Action**:
```bash
python3 Skills/Longevity_Aging/Cellular_Senescence_Agent/senescence_analyzer.py \
--rnaseq tissue_expression.tsv \
--singlecell tissue_scrnaseq.h5ad \
--signatures fridman_sasp,reactome_senescence \
--senolytic_prediction true \
--tissue liver \
--output senescence_report/
```
## Senescence Gene Signatures
| Signature | Genes | Application |
|-----------|-------|-------------|
| Fridman (2017) | CDKN1A, CDKN2A, SERPINE1... | Pan-senescence |
| SenMayo | 125 genes | Tissue senescence |
| SASP Core | IL6, IL8, CXCL1, MMP1... | Secretory phenotype |
| p16/p21 pathway | CDKN2A, CDKN1A, MDM2... | Cell cycle arrest |
## SASP Components
**Pro-inflammatory**:
- Interleukins: IL-1α/β, IL-6, IL-8
- Chemokines: CXCL1, CXCL2, CCL2
- Growth factors: TGF-β, VEGF
**Matrix Remodeling**:
- MMPs: MMP1, MMP3, MMP10
- Serpins: PAI-1 (SERPINE1)
**Effects on Microenvironment**:
- Paracrine senescence spread
- Immune cell recruitment
- ECM remodeling
- Tumor promotion (chronic) vs suppression (acute)
## Senolytic Drugs
| Drug | Target | Clinical Status |
|------|--------|-----------------|
| Dasatinib | Src/tyrosine kinases | Trials (with Q) |
| Quercetin | PI3K, serpins | Trials (with D) |
| Navitoclax | BCL-2/BCL-xL | Trials |
| Fisetin | Multiple | Early trials |
| UBX1325 | BCL-xL | Phase 2 (macular) |
## AI/ML Components
**Senescence Classifier**:
- Multi-gene signature scoring
- ML classifiers on expression
- Single-cell senescence probability
**Drug Response**:
- GDSC/CCLE senescence sensitivity
- SASP-drug correlations
- Synergy predictions
**Aging Clock Integration**:
- Epigenetic age correlation
- Transcriptomic age
- Senescence-aging relationships
## Cancer Applications
**Therapy-Induced Senescence (TIS)**:
- Chemotherapy, radiation
- CDK4/6 inhibitors (palbociclib)
- Dual outcomes: tumor suppression vs SASP-driven recurrence
**Senescence + Senolytics**:
- Induce senescence → clear with senolytics
- "One-two punch" approach
- Clinical trials ongoing
## Prerequisites
* Python 3.10+
* Gene signature tools (GSVA, ssGSEA)
* Single-cell analysis (Scanpy)
* Drug response databases
## Related Skills
* Single_Cell - For scRNA-seq analysis
* Cancer_Metabolism_Agent - For metabolic senescence
* Tumor_Microenvironment - For SASP effects
## Research Applications
1. **Aging Research**: Quantify senescence burden
2. **Cancer Therapy**: Monitor TIS response
3. **Drug Development**: Senolytic efficacy
4. **Fibrosis**: Senescence in fibrotic disease
5. **Regeneration**: Senescence in tissue repair
## Author
AI Group - Biomedical AI Platform
<!-- AUTHOR_SIGNATURE: 9a7f3c2e-MD-BABU-MIA-2026-MSSM-SECURE -->
COMPATIBILITY & REFERENCES
Platform guidance
Imported from the listed AgentSkill.sh category. Complete supplied package files and notices are retained. Required external tools and credentials are not installed. No bundled code was executed during import. Individual agent task behavior has not been tested.
---name: liquid-biopsy-analytics-agent description: AI-powered comprehensive liquid biopsy analysis integrating ctDNA, CTCs, exosomes, and cfRNA for cancer detection, monitoring, and treatment guidance. license: MIT metadata: author: AI Group version: "1.0.0" created: "2026-01-19" compatibility:
Remove batch effects from RNA-seq data using ComBat, ComBat-Seq, limma removeBatchEffect, and SVA for unknown batch variables. Use when correcting batch effects in expression data.
This skill should be used when working with genomic interval data (BED files) for machine learning tasks. Use for training region embeddings (Region2Vec, BEDspace), single-cell ATAC-seq analysis (scEmbed), building consensus peaks (universes), or any ML-based analysis of genomic regions. Applies ...
Generate reproducible bioinformatics/data-science Methods + run documentation from workflow run artifacts (Nextflow/Snakemake/CWL), including a top-of-doc workflow summary, exact executed commands, tool versions, parameters, QC, and outputs.